This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Washington. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Innovations of Todd C McDevitt
Introduction
Todd C McDevitt is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly through his innovative work on streptavidin mutants. His research focuses on enhancing the functionality of streptavidin molecules, which are crucial in various biological applications.
Latest Patents
Todd C McDevitt holds a patent for "Streptavidin mutants having secondary functional domains." This patent describes streptavidin molecules that incorporate a secondary functional domain, such as a cell adhesion peptide, without interfering with biotin binding. The preferred embodiment features the cell adhesion peptide arginine-glycine-aspartate (Arg-Gly-Asp) (RGD) strategically placed within the streptavidin amino acid sequence. This innovation allows for improved interactions with cells or molecules, making it particularly useful for applications in vascular devices or prostheses. Todd has 1 patent to his name.
Career Highlights
Todd C McDevitt is affiliated with the University of Washington, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in medical devices and therapeutic strategies.
Collaborations
Some of Todd's notable coworkers include Patrick S Stayton and Kjell E Nelson. Their collaborative efforts contribute to the innovative research environment at the University of Washington.
Conclusion
Todd C McDevitt's contributions to the field of biotechnology through his patent on streptavidin mutants highlight his innovative spirit and dedication to advancing medical technology. His work continues to pave the way for new applications in the biomedical field.